Hepatitis C drugs on every 2026 Tennessee Part D plan
Pick a drug class, or type the drugs you want to check, and see which of the 12 stand-alone Part D plans in Tennessee cover each one, on what tier, and with what restrictions.
- Covered
- Covered, needs prior authorization (PA) or step therapy (ST)
- Not on the formulary
- QL 60/30d = quantity limit, 60 units per 30 days
12 plans, cheapest premium first. Scroll sideways for all of them →
| Drug | Humana Basic Rx Plan$0.00/moS5884-106 | Wellcare Value Script$3.60/moS4802-147 | Wellcare Classic$3.70/moS4802-071 | Humana Value Rx Plan$37.70/moS5884-191 | AARP Medicare Rx Saver from UHC$63.20/moS5921-357 | BlueRx Essential$76.20/moS1030-006 | HealthSpring Extra Rx$77.50/moS5617-362 | HealthSpring Assurance Rx$87.20/moS5617-220 | SilverScript Choice$97.30/moS5601-024 | Humana Premier Rx Plan$108.60/moS5884-158 | AARP Medicare Rx Preferred from UHC$119.30/moS5921-393 | BlueRx Enhanced Plus$129.50/moS1030-001 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Epclusasofosbuvir and velpatasvir | Tier 5PA25%QL 28/28d | Not covered | Not covered | Tier 5PA26%QL 28/28d | Not covered | Not covered | Tier 5PA25%QL 28/28d | Tier 5PA25%QL 28/28d | Tier 5PA25% | Tier 5PA33%QL 28/28d | Not covered | Not covered |
| sofosbuvir-velpatasvirgeneric Epclusa | Not covered | Tier 5PA25%QL 28/28d | Tier 5PA25%QL 28/28d | Not covered | Tier 5PA25%QL 28/28d | Not covered | Not covered | Not covered | Not covered | Not covered | Tier 5PA31%QL 28/28d | Not covered |
| Mavyretglecaprevir and pibrentasvir | Not covered | Not covered | Not covered | Not covered | Tier 5PA25%QL 140/28d | Tier 5PA25% | Not covered | Not covered | Tier 5PA25% | Not covered | Tier 5PA31%QL 140/28d | Tier 5PA31% |
| Harvoniledipasvir and sofosbuvir | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Tier 5PA25%QL 28/28d | Tier 5PA25%QL 28/28d | Not covered | Not covered | Not covered | Not covered |
| ledipasvir-sofosbuvirgeneric Harvoni | Not covered | Tier 5PA25%QL 28/28d | Tier 5PA25%QL 28/28d | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered |
| Vosevisofosbuvir | Tier 5PA25%QL 28/28d | Not covered | Not covered | Tier 5PA26%QL 28/28d | Tier 5PA25%QL 28/28d | Tier 5PA25% | Tier 5PA25%QL 28/28d | Tier 5PA25%QL 28/28d | Tier 5PA25%QL 28/28d | Tier 5PA33%QL 28/28d | Tier 5PA31%QL 28/28d | Tier 5PA31% |
Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.